ELV · Elevance Health, Inc. · Documents
Market Cap
$87.17B
Shares
216.87M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-15 | 2026-06-30 | |
| 8-K | 2026-07-15 | — | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-05-13 | — | |
| 8-K | 2026-04-22 | — | |
| 10-Q | 2026-04-22 | 2026-03-31 | |
| DEF 14A | 2026-03-27 | 2026-05-13 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-06 | 2025-12-31 | |
| 8-K | 2026-01-28 | — | |
| 8-K | 2025-12-10 | — | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-21 | — | |
| 10-Q | 2025-10-21 | 2025-09-30 | |
| 8-K | 2025-09-15 | 2025-09-08 | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-07-28 | — | |
| 8-K | 2025-07-17 | — | |
| 10-Q | 2025-07-17 | 2025-06-30 | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-04-22 | — | |
| 10-Q | 2025-04-22 | 2025-03-31 | |
| 8-K | 2025-04-17 | — | |
| DEF 14A | 2025-03-28 | 2025-05-14 | |
| 8-K | 2025-03-10 | — | |
| 10-K | 2025-02-20 | 2024-12-31 | |
| 8-K | 2025-01-23 | — | |
| 8-K | 2024-10-31 | 2024-10-22 | |
| 8-K | 2024-10-17 | — | |
| 10-Q | 2024-10-17 | 2024-09-30 | |
| 10-Q | 2024-07-17 | 2024-06-30 | |
| 8-K | 2024-07-17 | — | |
| 8-K | 2024-06-12 | — | |
| 8-K | 2024-05-30 | 2024-05-20 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-04-18 | 2024-03-31 | |
| 8-K | 2024-04-18 | — | |
| DEF 14A | 2024-03-29 | 2024-05-15 | |
| 8-K | 2024-03-04 | — | |
| 10-K | 2024-02-21 | 2023-12-31 | |
| 8-K | 2024-01-25 | 2024-01-23 | |
| 8-K | 2024-01-24 | — | |
| 8-K | 2023-10-18 | — | |
| 10-Q | 2023-10-18 | 2023-09-30 | |
| 8-K | 2023-10-13 | — | |
| 8-K | 2023-10-05 | 2023-10-04 | |
| 10-Q/A | 2023-09-29 | 2023-06-30 |
Showing 1–50 of 111 filings
Key facts
CIK
1156039
CUSIP
036752103
13F (30d)
674 filings
635 filers
Visit website
Investor relations